Receptos, Inc. 4
4 · Receptos, Inc. · Filed Aug 27, 2015
Insider Transaction Report
Form 4
Receptos, Inc.RCPT
MAST ERLE T
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-08-27$213.23/sh−18,800$4,008,724→ 0 totalExercise: $18.77Exp: 2023-07-16→ Common Stock (18,800 underlying) - Disposition from Tender
Common Stock
2015-08-25−300→ 7,400 total - Disposition to Issuer
Stock Option (right to buy)
2015-08-27$204.56/sh−9,400$1,922,864→ 0 totalExercise: $27.44Exp: 2024-06-02→ Common Stock (9,400 underlying) - Disposition to Issuer
Common Stock
2015-08-27−7,400→ 0 total
Footnotes (4)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 14, 2015, by and among Receptos, Inc., a Delaware corporation (the "Company"), Celgene Corporation, a Delaware corporation ("Parent"), and Strix Corporation, a Delaware corporation and a wholly owned subsidiary of Parent, the reporting person disposed of 7,700 shares of the Company's common stock in the merger and Offer (as defined in the Merger Agreement) in exchange for $232.00 per share in cash (the "Offer Price") which number includes 7,400 unvested time-based restricted stock units.
- [F2]Pursuant to the terms of the Merger Agreement, each stock option of the Company, whether vested or unvested, was cancelled in exchange for a cash payment with respect thereto equal to the product of (A) the excess, if any, of (1) the Offer Price over (2) the exercise price per share of such option, and (B) the number of shares of common stock underlying such option.
- [F3]The original vesting term of the option was as follows: the option vested in 36 equal monthly installments commencing on July 17, 2013.
- [F4]The original vesting term of the option was as follows: the option vested in 12 equal monthly installments commencing on June 3, 2014.